Infinium Pharmachem Ltd

AI
Infinium Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Infinium Pharmachem Ltd

₹ 286 -3.54%
23 Oct - close price
infiniumpharmachem.com NSE - SME: INFINIUM
About

Incorporated in 2003, Infinium Pharmachem Ltd manufactures and sells Iodian based Pharmaceutical Intermediates[1]

Key Points

Business Overview:[1]
IPL is a GMP compliant, FDA Approved and ISO 9001-2015 certified coimpany which does development, manufacture, and export of Iodine Derivatives & API. Currently, it has 250+ intermediates and 15+ APIs. It supplies a range of Iodine derivatives on Order to Made basis

Website NSE - ST
  • Market Cap ₹ 446 Cr.
  • Current Price ₹ 286
  • High / Low ₹ 324 / 189
  • Stock P/E 44.5
  • Book Value ₹ 74.3
  • Dividend Yield 0.00 %
  • ROCE 11.2 %
  • ROE 9.05 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.7% over last 3 years.
  • Promoter holding has decreased over last 3 years: -8.14%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
58 51 72 71 66 73 84
51 41 64 64 57 64 76
Operating Profit 8 10 8 7 8 9 8
OPM % 13% 19% 11% 10% 13% 12% 10%
1 0 1 1 1 0 1
Interest 1 1 1 1 2 1 1
Depreciation 0 1 1 1 2 1 1
Profit before tax 7 8 7 6 6 6 7
Tax % 25% 25% 26% 29% 25% 26% 26%
5 6 5 4 5 5 5
EPS in Rs 4.90 4.40 3.56 2.85 2.89 2.98 3.45
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
36 55 74 101 122 137 156
33 50 65 86 105 122 139
Operating Profit 3 5 9 15 17 15 17
OPM % 7% 9% 12% 15% 14% 11% 11%
1 1 1 1 2 2 1
Interest 1 1 2 3 2 3 2
Depreciation 1 1 1 1 2 3 3
Profit before tax 1 4 7 12 15 12 14
Tax % 27% 28% 26% 25% 25% 27% 26%
1 3 6 9 11 8 10
EPS in Rs 1.02 2.72 5.50 8.97 7.97 5.44 6.43
Dividend Payout % 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 23%
3 Years: 16%
TTM: 14%
Compounded Profit Growth
10 Years: %
5 Years: 30%
3 Years: 3%
TTM: 18%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 5%
1 Year: 13%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 13%
Last Year: 9%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 1 1 1 5 14 16 16
Reserves 3 6 12 17 44 90 100
9 11 23 26 8 45 15
7 13 14 13 12 15 10
Total Liabilities 21 31 49 60 78 166 141
4 4 4 16 16 17 17
CWIP 0 4 8 0 0 1 7
Investments 0 0 0 0 0 16 16
16 22 37 44 61 133 101
Total Assets 21 31 49 60 78 166 141

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
2 7 9 7 -15 -26 36
-1 -5 -7 -3 -3 -23 -10
-1 -1 -2 -3 23 74 -32
Net Cash Flow 0 1 0 2 5 25 -6
Free Cash Flow 1 2 4 3 -18 -30 27
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 103% 160% 127% 69% -65% -150% 232%

Ratios

Standalone / View Consolidated

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 75 70 64 55 71 92 73
Inventory Days 90 80 96 93 88 118 90
Days Payable 80 105 69 45 29 36 10
Cash Conversion Cycle 85 45 91 102 129 173 153
Working Capital Days 54 21 47 35 112 104 109
ROCE % 32% 34% 37% 29% 13% 11%

Insights

In beta
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2026
Export Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Number of Customers
count
Production Volume
MT
EU-REACH Registrations (Approved)
count
Number of APIs
count
Number of Iodine Derivatives
count
Installed Capacity
MTPA
Top 5 Customers Revenue Share
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Nov 2024Mar 2025Sep 2025Mar 2026Sep 2026
73.05% 73.05% 73.05% 65.24% 65.24% 59.91% 64.91% 64.91%
0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 0.21% 0.23%
26.95% 26.95% 26.95% 34.76% 34.76% 40.07% 34.87% 34.86%
No. of Shareholders 6467719479989581,0521,0611,086

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls